| Typicality: | 0.364 |
| Saliency: | 0.320 |
| over the last decade | 4 | temporal |
| between the drug’s launch | 4 | temporal |
| previously | 3 | temporal |
| death → be reported to → the fda | 21 |
| negative | neutral | positive |
| 0.616 | 0.363 | 0.022 |
| Raw frequency | 21 |
| Normalized frequency | 0.320 |
| Modifier score | 0.700 |
| Perplexity | 19.333 |